22 Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Nabriva Therapeutics plc NBRV rose 84.4 percent to $12.65 in pre-market trading after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints.
  • Silver Spring Networks Inc SSNI rose 23.1 percent to $16.00 in pre-market trading. Itron, Inc. ITRI announced plans to acquire Silver Spring Networks for $16.25 per share.
  • Orbital ATK Inc OA rose 19.5 percent to $131.50 in pre-market trading. Northrop Grumman Corporation NOC announced plans to acquire Orbital ATK for $7.8 billion in cash.
  • Pluristem Therapeutics Inc. PSTI rose 10.5 percent to $1.48 in pre-market trading after the company disclosed that it has been granted FDA Fast Track Designation for PLX-PAD.
  • BioTime, Inc. BTX rose 10.2 percent to $3.14 in pre-market trading after the company reported that it has been awarded a $1.56 million grant from the National Institutes of Health.
  • Arrowhead Pharmaceuticals Inc ARWR rose 7.9 percent to $3.56 in pre-market trading after surging 18.28 percent on Friday. William Blair upgraded Arrowhead Pharmaceuticals from Market Perform to Outperform.
  • Cogint, Inc. COGT rose 6.3 percent to $5.05 in pre-market trading after falling 4.04 percent on Friday.
  • BlackBerry Ltd BBRY shares rose 6.2 percent to $9.84 in pre-market trading. BlackBerry is expected to release Q2 results on September 28, 2017.
  • BiondVax Pharmaceuticals Ltd (ADR) BVXV rose 5.6 percent to $7.50 in pre-market trading after gaining 1.07 percent on Friday.
  • Ballard Power Systems Inc. (USA) BLDP rose 5.2 percent to $4.66 in pre-market trading after the company reported that it has received a purchase order from Nisshinbo for the development program to advance use of Non Precious Metal Catalyst fuel cells in material handling.
  • NewLink Genetics Corp NLNK shares rose 5.2 percent to $13.33 in pre-market trading after falling 3.94 percent on Friday.
  • Rite Aid Corporation RAD rose 5 percent to $2.76 in pre-market trading after gaining 5.20 percent on Friday.
  • Pain Therapeutics, Inc. PTIE shares rose 2.9 percent to $4.00 in the pre-market trading session after the company announced that it has been awarded a $2.2 million grant from the National Institute on Drug Abuse and $1.8 million grant from the National Institutes of Health.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Helios and Matheson Analytics Inc HMNY shares fell 14.2 percent to $3.15 in pre-market trading after climbing 39.54 percent on Friday.
  • PDC Energy Inc PDCE shares fell 5.6 percent to $41.35 in pre-market trading after rising 0.48 percent on Friday.
  • Neos Therapeutics Inc NEOS fell 4.4 percent to $8.80 in pre-market trading. Neos Therapeutics disclosed that it has received the FDA approval for Adzenys ER.
  • 22nd Century Group Inc XXII fell 4.1 percent to $3.08 in pre-market trading after gaining 6.29 percent on Friday.
  • Royal Gold, Inc (USA) RGLD shares fell 3.9 percent to $86.25 in pre-market trading after dropping 0.54 percent on Friday.
  • Harmony Gold Mining Co. (ADR). HMY shares fell 3.7 percent to $2.06 in pre-market trading after rising 2.88 percent on Friday.
  • Cedar Fair, L.P. FUN fell 3.3 percent to $62.52 in pre-market trading after dropping 0.52 percent on Frisday.
  • AngloGold Ashanti Limited (ADR) AU fell 2.7 percent to $9.68 after rising 1.74 percent on Friday.
  • Chimera Investment Corporation CIM fell 2.6 percent to $18.59 in pre-market trading after gaining 0.47 percent on Friday.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersLosersTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...